ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
702 hedge funds and large institutions have $38.8B invested in Alexion Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 240 increasing their positions, 293 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% less first-time investments, than exits
New positions opened: 65 | Existing positions closed: 101
73% less call options, than puts
Call options by funds: $108M | Put options by funds: $402M
Holders
702
Holding in Top 10
77
Calls
$108M
Puts
$402M
Top Buyers
| 1 | +$526M | |
| 2 | +$418M | |
| 3 | +$355M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$262M |
| 5 |
DKCM
Davidson Kempner Capital Management
New York
|
+$259M |
Top Sellers
| 1 | -$611M | |
| 2 | -$265M | |
| 3 | -$238M | |
| 4 |
PC
Paulson & Co
New York
|
-$214M |
| 5 |
Barclays
London,
United Kingdom
|
-$207M |